LOW-VOLUME · SEX-BALANCED
desonide Side Effects
desonide (also sold as DesOwen) is a LOW-VOLUME FAERS extract #396 of 524 by FAERS report count. Still opens on SEX-BALANCED: 65% of sex-coded reports are female (2,806 F / 1,527 M).
Data updated 2026-05-15
- 4,709
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
desonide reporting skew - 65% of sex-coded reports are female (2,806 F / 1,527 M). Volume band LOW-VOLUME #396 of 524 by FAERS report count; caseload SIGNAL.
Thinner FAERS extract for desonide (DesOwen) (4,709 reports #396 of 524 by FAERS report count). 65% of sex-coded reports are female (2,806 F / 1,527 M). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2004–2025). Stamps SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
MACULAR DEGENERATION leads 773 of 4,709 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (820 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death appears on 186 reports (3.9% - MARKED). Reactions below co-occur in those rows only.
| Reaction | Reports |
|---|---|
| DEATH | 83 |
| PNEUMONIA | 16 |
| RENAL FAILURE | 14 |
| DYSPNOEA | 12 |
| FALL | 12 |
| NAUSEA | 12 |
| PAIN | 12 |
| ACUTE KIDNEY INJURY | 11 |
| DIARRHOEA | 11 |
| FATIGUE | 11 |
| ANAEMIA | 9 |
| ASTHENIA | 9 |
| PLEURAL EFFUSION | 9 |
| RESPIRATORY FAILURE | 9 |
| VOMITING | 9 |
| CARDIAC FAILURE | 8 |
| SEPTIC SHOCK | 8 |
| ABDOMINAL PAIN | 7 |
| DISEASE PROGRESSION | 7 |
Reactions in Hospitalization Reports
Hospitalization mid-share (1,057, 22.4%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| PAIN | 248 |
| PYREXIA | 248 |
| NAUSEA | 244 |
| WEIGHT DECREASED | 224 |
| MACULAR DEGENERATION | 221 |
| MALAISE | 216 |
| CHRONIC SINUSITIS | 210 |
| THERAPEUTIC PRODUCT EFFECT INCOMPLETE | 204 |
| PARAESTHESIA ORAL | 195 |
| ABDOMINAL PAIN | 192 |
| INFUSION RELATED REACTION | 185 |
| HEADACHE | 183 |
| DYSPEPSIA | 182 |
| PROCEDURAL PAIN | 177 |
| ANAEMIA | 173 |
| ERYTHEMA | 165 |
| CONSTIPATION | 161 |
| HAEMATOCHEZIA | 159 |
How to read desonide FAERS figures (SIGNAL · DEATH-MARKED · HOSP-MID)
FAERS holds 4,709 voluntary reports linked to desonide (DesOwen), 2004-2025. Death is listed on 186 (3.9%). Hospitalization appears on 1,057 (22.4%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with desonide
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-MID stamps.
ABS(total_reports) peer at 4,692 FAERS cases (Δ 17 lighter vs desonide); DEATH-MARKED · HOSP-HEAVY · FEMALE-LED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 4,670 FAERS cases (Δ 39 lighter vs desonide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 4,779 FAERS cases (Δ 70 heavier vs desonide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 4,979 FAERS cases (Δ 270 heavier vs desonide); DEATH-HEAVY · HOSP-HEAVY · MALE-LED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 58.2 pp vs desonide's DEATH-MARKED): CASELOAD · HOSP-MID.
desonide stamps SIGNAL · SEX-BALANCED; class peers and methodology beat restating the same FAERS caveats on every effects URL.